<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04631796</url>
  </required_header>
  <id_info>
    <org_study_id>CLY935-E006</org_study_id>
    <nct_id>NCT04631796</nct_id>
  </id_info>
  <brief_title>Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens</brief_title>
  <official_title>Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the overall clinical performance of an&#xD;
      investigational silicone hydrogel contact lens over 2 weeks of daily wear.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will attend a Screening visit, a Dispense visit (0 to 4 days later), and Week 2&#xD;
      Follow-up visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 3, 2020</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Front surface wettability</measure>
    <time_frame>Week 2, at least 6 hours after lens insertion</time_frame>
    <description>Front surface wettability will be collected on a 5-point scale for each eye</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>LID020098 contact lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lehfilcon A contact lenses worn in both eyes for 2 weeks. Lenses will be removed nightly for cleaning and disinfection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lehfilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses with investigational coating</description>
    <arm_group_label>LID020098 contact lenses</arm_group_label>
    <other_name>LID020098</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multipurpose disinfection solution</intervention_name>
    <description>Solution for cleaning, disinfecting, and reconditioning silicone hydrogel contact lenses</description>
    <arm_group_label>LID020098 contact lenses</arm_group_label>
    <other_name>OPTI-FREE® RepleniSH®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Understand and sign an Informed Consent that has been approved by an Institutional&#xD;
             Review Board.&#xD;
&#xD;
          -  Successful wear of spherical weekly/monthly soft contact lenses in both eyes for a&#xD;
             minimum of 5 days per week and 8 hours per day during the past 3 months.&#xD;
&#xD;
          -  Willing to stop wearing habitual contact lenses for the duration of study&#xD;
             participation.&#xD;
&#xD;
          -  Other protocol-defined inclusion criteria may apply.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any condition that contraindicates contact lens wear, as determined by the&#xD;
             Investigator.&#xD;
&#xD;
          -  Any use of systemic or ocular medications that contraindicates contact lens wear, as&#xD;
             determined by the Investigator.&#xD;
&#xD;
          -  History of refractive surgery or plan to have refractive surgery during the study.&#xD;
&#xD;
          -  Current or history of dry eye in either eye that, in the opinion of the Investigator,&#xD;
             would preclude contact lens wear.&#xD;
&#xD;
          -  Habitual contact lenses worn in an extended wear modality (routinely sleeping in&#xD;
             lenses for at least 1 night per week) over the last 3 months prior to enrollment.&#xD;
&#xD;
          -  Any use of topical ocular medications or artificial tear or rewetting drops that would&#xD;
             require instillation during contact lens wear.&#xD;
&#xD;
          -  Monovision or multifocal contact lens wear.&#xD;
&#xD;
          -  Other protocol-defined exclusion criteria may apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sr. Clinical Trial Lead, CDMA Vision Care</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Powell</city>
        <state>Ohio</state>
        <zip>43065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vision</keyword>
  <keyword>Contact lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

